ZNF573 promoter methylation

ZNF573 promoter methylation predicts prostate cancer diagnosis in silico (AUC 0.847).

“These four DNA methylation markers effectively distinguished PCa from benign prostatic hyperplasia (BPH) with high AUC (0.847), which was superior to PSA.”

In silicodistinguishing PCa from BPH

Aging-associated ZNF573 methylation regulates RNF19B-PIK3CA ubiquitination to promote prostate cancer

Oncogene·Sep 19, 2025